Literature DB >> 24037310

The up-regulation of cysteine-rich protein 61 induced by transforming growth factor beta enhances osteosarcoma cell migration.

Jun Chen1, Yang Song, Jing Yang, Li Gong, Peng Zhao, Yong Zhang, Haichuan Su.   

Abstract

Overexpressed cysteine-rich protein 61 (Cyr61) is believed to enhance osteosarcoma (OS) cell metastasis, but the mechanism of Cyr61 overexpression in OS is not clear so far. In this study 33 OS samples were analyzed by immunostaining and focused on two parts: the correlation between overexpression of Cyr61 and OS metastasis; the mechanism of regulating Cyr61 expression in OS. Twenty-five out of 33 cases (75.76 %) with metastasis showed high expression of Cyr61. Furthermore, Cyr61 expression in Saos-2 cells was reduced by siRNA, and lower expression of Cyr61 in Saos-2 cell resulted in a cell migration deficiency and had no effect on cell proliferation. Particularly, Cyr61 expression was significantly increased in Saos-2 cells in response to different dosages of transforming growth factor beta (TGF-β), indicating that the expression of Cyr61 is TGF-β dependent. A transwell assay showed that Saos-2 cells stimulated with TGF-β had a greater capacity for migration than the control cells. The p38 MAPK-specific inhibitor SB203580 was able to reduce Cyr61 expression and inhibit the migration of Saos-2 cells stimulated with TGF-β. These results obtained provide new evidence that overexpressed Cyr61 plays a key role in the metastasis of OS cells and Cyr61 is a potential target downstream of TGF-β/p38 MAPK to regulate cell migration.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24037310     DOI: 10.1007/s11010-013-1807-3

Source DB:  PubMed          Journal:  Mol Cell Biochem        ISSN: 0300-8177            Impact factor:   3.396


  35 in total

1.  RLIM interacts with Smurf2 and promotes TGF-β induced U2OS cell migration.

Authors:  Yongsheng Huang; Yang Yang; Rui Gao; Xianmei Yang; Xiaohua Yan; Chenji Wang; Sirui Jiang; Long Yu
Journal:  Biochem Biophys Res Commun       Date:  2011-09-17       Impact factor: 3.575

2.  Cyr61 expression in osteosarcoma indicates poor prognosis and promotes intratibial growth and lung metastasis in mice.

Authors:  Adam A Sabile; Matthias J E Arlt; Roman Muff; Beata Bode; Bettina Langsam; Josefine Bertz; Thorsten Jentzsch; Gabor J Puskas; Walter Born; Bruno Fuchs
Journal:  J Bone Miner Res       Date:  2012-01       Impact factor: 6.741

3.  Gr-1+CD11b+ cells are responsible for tumor promoting effect of TGF-β in breast cancer progression.

Authors:  Zhaoyang Li; Yanli Pang; Sudheer Kumar Gara; B R Achyut; Christopher Heger; Paul K Goldsmith; Scott Lonning; Li Yang
Journal:  Int J Cancer       Date:  2012-05-08       Impact factor: 7.396

4.  Expression and regulation of CCN genes in murine osteoblasts.

Authors:  Muriel S Parisi; Elizabetta Gazzerro; Sheila Rydziel; Ernesto Canalis
Journal:  Bone       Date:  2005-11-28       Impact factor: 4.398

5.  Involvement of CYR61 and CTGF in the fascin-mediated proliferation and invasiveness of esophageal squamous cell carcinomas cells.

Authors:  Jian-Jun Xie; Li-Yan Xu; Jian-Yi Wu; Zhong-Ying Shen; Qing Zhao; Ze-Peng Du; Zhuo Lv; Wei Gu; Feng Pan; Xiu-E Xu; Dong Xie; En-Min Li
Journal:  Am J Pathol       Date:  2010-01-07       Impact factor: 4.307

6.  The expression of novH in adrenocortical cells is down-regulated by TGFbeta 1 through c-Jun in a Smad-independent manner.

Authors:  Jérôme Lafont; Maryvonne Laurent; Hélène Thibout; François Lallemand; Yves Le Bouc; Azeddine Atfi; Cécile Martinerie
Journal:  J Biol Chem       Date:  2002-07-30       Impact factor: 5.157

7.  Stromal COX-2 signaling activated by deoxycholic acid mediates proliferation and invasiveness of colorectal epithelial cancer cells.

Authors:  Yingting Zhu; Min Zhu; Peter Lance
Journal:  Biochem Biophys Res Commun       Date:  2012-08-02       Impact factor: 3.575

Review 8.  CCN proteins: multifunctional signalling regulators.

Authors:  Bernard Perbal
Journal:  Lancet       Date:  2004-01-03       Impact factor: 79.321

9.  Expression of transforming growth factor-beta (TGF-beta) receptors, TGF-beta 1 and TGF-beta 2 production and autocrine growth control in osteosarcoma cells.

Authors:  P Kloen; C L Jennings; M C Gebhardt; D S Springfield; H J Mankin
Journal:  Int J Cancer       Date:  1994-08-01       Impact factor: 7.396

10.  A meta-analysis of osteosarcoma outcomes in the modern medical era.

Authors:  Daniel C Allison; Scott C Carney; Elke R Ahlmann; Andrew Hendifar; Sant Chawla; Alex Fedenko; Constance Angeles; Lawrence R Menendez
Journal:  Sarcoma       Date:  2012-03-18
View more
  8 in total

1.  Dexamethasone and lenvatinib inhibit migration and invasion of non-small cell lung cancer by regulating EKR/AKT and VEGF signal pathways.

Authors:  Daye Zhang; Yongxiang Zhang; Zeyuan Cai; Ying Tu; Zhansong Hu
Journal:  Exp Ther Med       Date:  2019-11-21       Impact factor: 2.447

2.  Dexamethasone Inhibits TGF-β1-Induced Cell Migration by Regulating the ERK and AKT Pathways in Human Colon Cancer Cells Via CYR61.

Authors:  Sanghoon Han; Ngoc Thuy Bui; Manh Tin Ho; Young Mee Kim; Moonjae Cho; Dong Bok Shin
Journal:  Cancer Res Treat       Date:  2015-12-15       Impact factor: 4.679

Review 3.  TGF-β Signaling in Bone Remodeling and Osteosarcoma Progression.

Authors:  Audrey Lamora; Julie Talbot; Mathilde Mullard; Benedicte Brounais-Le Royer; Françoise Redini; Franck Verrecchia
Journal:  J Clin Med       Date:  2016-11-03       Impact factor: 4.241

4.  Targeting cysteine-rich angiogenic inducer-61 by antibody immunotherapy suppresses growth and migration of non-small cell lung cancer.

Authors:  Xinpeng Li; Naxin Yuan; Lingdan Lin; Lixia Yin; Yiqing Qu
Journal:  Exp Ther Med       Date:  2018-06-08       Impact factor: 2.447

5.  Quercetin Suppresses CYR61-Mediated Multidrug Resistance in Human Gastric Adenocarcinoma AGS Cells.

Authors:  Ho Bong Hyun; Jeong Yong Moon; Somi Kim Cho
Journal:  Molecules       Date:  2018-01-24       Impact factor: 4.411

6.  TGF‑β inhibitor RepSox suppresses osteosarcoma via the JNK/Smad3 signaling pathway.

Authors:  Dengwei He; Jiawei Gao; Lin Zheng; Shijie Liu; Lin Ye; Hehuan Lai; Bin Pan; Wenzheng Pan; Chao Lou; Zhenzhong Chen; Shunwu Fan
Journal:  Int J Oncol       Date:  2021-09-17       Impact factor: 5.650

Review 7.  Transforming Growth Factor-β Signaling Plays a Pivotal Role in the Interplay Between Osteosarcoma Cells and Their Microenvironment.

Authors:  Franck Verrecchia; Françoise Rédini
Journal:  Front Oncol       Date:  2018-04-30       Impact factor: 6.244

Review 8.  CCN proteins in the musculoskeletal system: current understanding and challenges in physiology and pathology.

Authors:  Veronica Giusti; Katia Scotlandi
Journal:  J Cell Commun Signal       Date:  2021-07-06       Impact factor: 5.782

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.